Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic uses of drug-carrier systems for imidazole-containing dipeptide compounds that act as pharmacological chaperones and have significant impact on the treatment of chronic diseases associated with increased oxidative stress and the formation of advanced glycation end products.
Babizhayev MA, Yegorov YE. Babizhayev MA, et al. Crit Rev Ther Drug Carrier Syst. 2010;27(2):85-154. doi: 10.1615/critrevtherdrugcarriersyst.v27.i2.10. Crit Rev Ther Drug Carrier Syst. 2010. PMID: 20486899 Review.
Water-structuring technology with the molecular chaperone proteins: indicated application of the α-crystallin domains and imidazole-containing peptidomimetics in cosmetic skin care systems or dermatological therapeutic drug carrier formulations.
Babizhayev MA, Nikolayev GM, Nikolayeva JG, Yegorov YE. Babizhayev MA, et al. Crit Rev Ther Drug Carrier Syst. 2011;28(3):203-53. doi: 10.1615/critrevtherdrugcarriersyst.v28.i3.10. Crit Rev Ther Drug Carrier Syst. 2011. PMID: 21663576
Advanced drug delivery of N-acetylcarnosine (N-acetyl-beta-alanyl-L-histidine), carcinine (beta-alanylhistamine) and L-carnosine (beta-alanyl-L-histidine) in targeting peptide compounds as pharmacological chaperones for use in tissue engineering, human disease management and therapy: from in vitro to the clinic.
Babizhayev MA, Yegorov YE. Babizhayev MA, et al. Recent Pat Drug Deliv Formul. 2010 Nov;4(3):198-230. doi: 10.2174/187221110793237547. Recent Pat Drug Deliv Formul. 2010. PMID: 20863274 Review.
Reactive Oxygen Species and the Aging Eye: Specific Role of Metabolically Active Mitochondria in Maintaining Lens Function and in the Initiation of the Oxidation-Induced Maturity Onset Cataract--A Novel Platform of Mitochondria-Targeted Antioxidants With Broad Therapeutic Potential for Redox Regulation and Detoxification of Oxidants in Eye Diseases.
Babizhayev MA, Yegorov YE. Babizhayev MA, et al. Am J Ther. 2016 Jan-Feb;23(1):e98-117. doi: 10.1097/MJT.0b013e3181ea31ff. Am J Ther. 2016. PMID: 21048433 Review.
88 results